Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, December 7, 2023 · 673,436,889 Articles · 3+ Million Readers

Global Biomarkers Market to Witness Striking Growth, Estimated to Reach $104.85 Billion by 2027

The Business Research Company's Biomarkers Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032

The Business Research Company's Biomarkers Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032

The Business Research Company's Biomarkers Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032

The market size of the biomarkers is expected to grow to $104.85 billion in 2027 at a CAGR of 14.2%.”
— The Business Research Company

LONDON, GREATER LONDON, UK, November 20, 2023 / -- The global biomarkers market is anticipated to expand from $54.4 billion in 2022 to $61.72 billion in 2023, demonstrating a robust Compound Annual Growth Rate (CAGR) of 13.4%. Despite disruptions caused by the Russia-Ukraine conflict and the pandemic, the market is set to surge to $104.85 billion by 2027, propelled by the escalating prevalence of heart diseases and the need for advanced diagnostic solutions facilitated by biomarkers.

Surging Incidence of Heart Diseases Drives Market Expansion

The rising prevalence of heart diseases stands as a prominent factor contributing to the growth of the biomarkers market, with biomarkers playing a crucial role in the diagnosis and monitoring of heart conditions. Notably, biomarkers such as natriuretic peptides and high-sensitivity C-reactive protein aid in the identification and management of heart failure. According to the National Center for Health Statistics (NCHS) and National Vital Statistics System (NVSS), the United States witnessed a significant uptick in heart disease-related deaths in 2020, marking the most substantial increase since 2012. Given the surge in heart diseases and related fatalities, the demand for biomarkers is expected to witness a notable upsurge.

Explore the global biomarkers market with comprehensive insights:

Key Players and Market Trends

Enzo Biochem Inc., Bio-Rad Laboratories Inc., Merck KGaA, and other major players are actively engaged in the biomarkers market, focusing on research and development endeavors and strategic agreements to foster product innovation and market expansion. Notably, agreements between companies are increasingly shaping the landscape, leading to the introduction of novel solutions and collaborative ventures aimed at bolstering the overall market position. Thermo Fisher Scientific, for instance, has entered into various collaborations to enhance the clinical implementation of biomarkers and streamline the transition from biomarker research to clinical application, signifying a notable trend in the industry.


• Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers
• Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases
• Type: Biomarker Of Exposure, Biomarker Of Diseases
• Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies
• Application: Risk Assessment, Development of Molecular Diagnostic, Disease Diagnosis, Drug Discovery And Development, Drug Formulation, Forensic Application, Other Applications (DNA Fingerprinting And Others)

Geographical Insights: North America Leads, Asia-Pacific Witnessing Rapid Growth

North America spearheaded the biomarkers market in 2022, while Asia-Pacific is poised to be the fastest-growing region in the forecast period. The comprehensive report provides in-depth insights into regional dynamics, market trends, and growth opportunities.

Access the complete report for an in-depth analysis of the global biomarkers market:

Biomarkers Global Market Report 2023from TBRC covers the following information:
•Market size date for the forecast period: Historical and Future
•Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•Market analysis by countries:Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

TheBiomarkers Global Market Report 2023byThe Business Research Company is the most comprehensive report that provides insights on biomarkers market size, biomarkers market drivers and trends, biomarkers market major players, biomarkers market competitors' revenues, market positioning, and biomarkers market growth across geographies.The biomarkers market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Renal Biomarkers Global Market Report 2023
Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2023
Cancer Biomarker Global Market Report 2023

About The Business Research Company
The Business Research Company has published over 3000+detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Check out our:
Healthcare Blog:
Global Market Model:

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media:

Accounting and Budgeting Software Market Insights, Growth Drivers, and Financial Innovations!

Powered by EIN Presswire

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release